Home/Publication/Ascent to Take Majority Interest in Pivot Path from Strides Pharma
Ascent to Take Majority Interest in Pivot Path from Strides Pharma 

30 Jun 2026

US$ 20.00

Ascent Capital alongside its co-investor Vintage Classic Ltd (together Ascent Consortium), will acquire a 65.1% stake...

Price / article: US$20.00
OR existing subscriber
Related Publications

5Y Capital, IDG Capital, ZhenFund and Gaorong Ventures were party to the seed funding round of Archon Robotics ......

Singapore-headquartered Clifford Capital, an infrastructure credit manager, has raised US$345 m so far for its ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.